Daicel Corporation (TYO:4202)

Japan flag Japan · Delayed Price · Currency is JPY
1,184.00
+6.00 (0.51%)
Apr 24, 2025, 3:30 PM JST
-17.09%
Market Cap 312.33B
Revenue (ttm) 576.33B
Net Income (ttm) 55.67B
Shares Out 265.13M
EPS (ttm) 202.18
PE Ratio 5.83
Forward PE 5.68
Dividend 60.00 (5.15%)
Ex-Dividend Date Mar 28, 2025
Volume 1,038,500
Average Volume 755,065
Open 1,180.00
Previous Close 1,178.00
Day's Range 1,179.50 - 1,192.00
52-Week Range 1,059.00 - 1,640.00
Beta 0.26
RSI 44.27
Earnings Date May 13, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, s... [Read more]

Sector Materials
Founded 1919
Employees 11,134
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4202
Full Company Profile

Financial Performance

In 2023, Daicel's revenue was 558.06 billion, an increase of 3.72% compared to the previous year's 538.03 billion. Earnings were 55.83 billion, an increase of 37.24%.

Financial Statements

News

There is no news available yet.